Ethical  ||| S:0 E:8 ||| JJ
issues  ||| S:8 E:15 ||| NNS
in  ||| S:15 E:18 ||| IN
adolescent  ||| S:18 E:29 ||| JJ
HIV  ||| S:29 E:33 ||| NNP
research  ||| S:33 E:42 ||| NN
in  ||| S:42 E:45 ||| IN
resource-limited  ||| S:45 E:62 ||| JJ
countries  ||| S:62 E:72 ||| NNS
Globally ||| S:72 E:80 ||| NNP
,  ||| S:80 E:82 ||| ,
there  ||| S:82 E:88 ||| EX
are  ||| S:88 E:92 ||| VBP
5  ||| S:92 E:94 ||| CD
million  ||| S:94 E:102 ||| CD
young  ||| S:102 E:108 ||| JJ
people  ||| S:108 E:115 ||| NNS
aged  ||| S:115 E:120 ||| VBN
15-24  ||| S:120 E:126 ||| CD
years  ||| S:126 E:132 ||| NNS
living  ||| S:132 E:139 ||| VBG
with  ||| S:139 E:144 ||| IN
HIV ||| S:144 E:147 ||| NNP
,  ||| S:147 E:149 ||| ,
and  ||| S:149 E:153 ||| CC
many  ||| S:153 E:158 ||| JJ
more  ||| S:158 E:163 ||| JJR
millions  ||| S:163 E:172 ||| NNS
are  ||| S:172 E:176 ||| VBP
at  ||| S:176 E:179 ||| IN
risk  ||| S:179 E:184 ||| NN
for  ||| S:184 E:188 ||| IN
HIV  ||| S:188 E:192 ||| NNP
acquisition ||| S:192 E:203 ||| NN
.  ||| S:203 E:205 ||| .
Compelling  ||| S:205 E:216 ||| JJ
research  ||| S:216 E:225 ||| NN
questions  ||| S:225 E:235 ||| NNS
exist  ||| S:235 E:241 ||| VBP
that  ||| S:241 E:246 ||| RB
require  ||| S:246 E:254 ||| VB
the  ||| S:254 E:258 ||| DT
involvement  ||| S:258 E:270 ||| NN
of  ||| S:270 E:273 ||| IN
young  ||| S:273 E:279 ||| JJ
people  ||| S:279 E:286 ||| NNS
and  ||| S:286 E:290 ||| CC
other  ||| S:290 E:296 ||| JJ
vulnerable  ||| S:296 E:307 ||| JJ
populations  ||| S:307 E:319 ||| NNS
in  ||| S:319 E:322 ||| IN
HIV-related  ||| S:322 E:334 ||| JJ
research  ||| S:334 E:343 ||| NN
in  ||| S:343 E:346 ||| IN
diverse  ||| S:346 E:354 ||| JJ
settings  ||| S:354 E:363 ||| NNS
around  ||| S:363 E:370 ||| IN
the  ||| S:370 E:374 ||| DT
world ||| S:374 E:379 ||| NN
.  ||| S:379 E:381 ||| .
Despite  ||| S:381 E:389 ||| IN
this ||| S:389 E:393 ||| DT
,  ||| S:393 E:395 ||| ,
there  ||| S:395 E:401 ||| EX
remains  ||| S:401 E:409 ||| VBZ
a  ||| S:409 E:411 ||| DT
reluctance  ||| S:411 E:422 ||| NN
to  ||| S:422 E:425 ||| TO
involve  ||| S:425 E:433 ||| VB
adolescent  ||| S:433 E:444 ||| JJ
participants ||| S:444 E:456 ||| NNS
,  ||| S:456 E:458 ||| ,
including  ||| S:458 E:468 ||| VBG
young  ||| S:468 E:474 ||| JJ
women ||| S:474 E:479 ||| NNS
,  ||| S:479 E:481 ||| ,
in  ||| S:481 E:484 ||| IN
clinical  ||| S:484 E:493 ||| JJ
research ||| S:493 E:501 ||| NN
.  ||| S:501 E:503 ||| .
Complex  ||| S:503 E:511 ||| JJ
and ||| S:511 E:514 ||| CC
,  ||| S:514 E:516 ||| ,
at  ||| S:516 E:519 ||| IN
times ||| S:519 E:524 ||| NNS
,  ||| S:524 E:526 ||| ,
contradictory  ||| S:526 E:540 ||| JJ
legal  ||| S:540 E:546 ||| JJ
and  ||| S:546 E:550 ||| CC
ethical  ||| S:550 E:558 ||| JJ
requirements  ||| S:558 E:571 ||| NNS
can  ||| S:571 E:575 ||| MD
be  ||| S:575 E:578 ||| VB
a  ||| S:578 E:580 ||| DT
challenge ||| S:580 E:589 ||| NN
.  ||| S:589 E:591 ||| .
Ethical  ||| S:591 E:599 ||| JJ
benchmarks  ||| S:599 E:610 ||| NNS
can  ||| S:610 E:614 ||| MD
be  ||| S:614 E:617 ||| VB
applied  ||| S:617 E:625 ||| VBN
to  ||| S:625 E:628 ||| TO
ensure  ||| S:628 E:635 ||| VB
that  ||| S:635 E:640 ||| DT
research  ||| S:640 E:649 ||| NN
meets  ||| S:649 E:655 ||| VBZ
high-level  ||| S:655 E:666 ||| JJ
standards  ||| S:666 E:676 ||| NNS
and  ||| S:676 E:680 ||| CC
is  ||| S:680 E:683 ||| VBZ
planned  ||| S:683 E:691 ||| VBN
for  ||| S:691 E:695 ||| IN
appropriately ||| S:695 E:708 ||| RB
.  ||| S:708 E:710 ||| .
